China’s RLX draws in $1.4bn from bigger US IPO

By Jonathan Breen
21 Jan 2021

Chinese vape company RLX Technology raised $1.4bn from its US listing this week, pricing the deal above the marketed range after a huge turnout from investors.

Lead underwriter Citi, with junior partner China Renaissance, launched bookbuilding for the trade on January 15. They immediately found investors eager for a piece of the IPO.

RLX, known for its Relx-branded products, is listing 116.5m American depository shares (ADS) on the New York Stock Exchange. Each ADS ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial